In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 5, 1997, Pages 1190-1192

  Watts, Jeffrey L ^a   Salmon, Sarah A ^a   Sanchez, Margaret S ^a   Yancey Jr , Robert J ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DANOFLOXACIN; ENROFLOXACIN; PD 140288; PREMAFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CATTLE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STREPTOCOCCUS; VETERINARY MEDICINE;

EID: 0030955057     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.5.1190     Document Type: Article

References (10)

1. Brown, S. A. 1996. Fluoroquinolones in animal health. J. Vet. Pharmacol. Ther. 19:1-14.
2. Giles, C. J., W. T. R. Grimshaw, D. J. Shanks, and D. G. Smith. 1991. Efficacy of danofloxacin in the therapy of acute bacterial pneumonia in housed beef cattle. Vet. Rec. 128:296-300.
3. Greene, C. E., and S. C. Budsberg. 1993. Veterinary use of quinolones, p. 473-488. In D. C. Hooper and J. S. Wolfson (ed.), Quinolone antimicrobial agents, 2nd ed. ASM Press, Washington, D.C.
4. National Committee for Clinical Laboratory Standards. 1993. Approved standard, M7-A3. Standard methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Wayne, Pa.
5. National Committee for Clinical Laboratory Standards. 1993. Approved standard, M11-A3. Methods for antimicrobial susceptibility testing of anaerobic bacteria. National Committee for Clinical Laboratory Standards, Wayne, Pa.
6. National Committee for Clinical Laboratory Standards. 1994. Proposed standard, M31-P. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. National Committee for Clinical Laboratory Standards, Wayne, Pa.
7. Salmon, S. A., J. L. Watts, C. A. Case, L. J. Hoffman, H. C. Wegner, and R. J. Yancey, Jr. 1995. Comparison of MICs of ceftiofur and other antimicrobial agents against bacterial pathogens of swine from the United States, Canada, and Denmark. J. Clin. Microbiol. 33:2435-2444.
8. Sanchez, M. S., C. W. Ford, and R. J. Yancey, Jr. 1986. Evaluation of antibacterial agents in a high-volume bovine polymorphonuclear neutrophil Staphylococcus aureus intracellular killing assay. Antimicrob. Agents Chemother. 29:634-638.
9. Watts, J. L., R. J. Yancey, Jr., S. A. Salmon, and C. A. Case. 1994. A 4-year survey of antimicrobial susceptibility trends for isolates form cattle with bovine respiratory disease in North America. J. Clin. Microbiol. 32:725-731.
10. Zerva, L., S. A. Marshall, and R. N. Jones. 1996. Premafloxacin: a projected veterinary use fluroquinolone with significant activity against multi-resistant gram-positive human pathogens. J. Antimicrob. Chemother. 38:742-744.